We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+6.28%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.31B
AUM Growth
-$78.9M
(-5.7%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-7.96%
Top 10 Holdings %
Top 10 Hldgs %
6.88%
Holding
1,081
New
330
Increased
200
Reduced
286
Closed
229
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$7.87M |
| 2 |
UiPath
PATH
|
+$6.99M |
| 3 |
Marqeta
MQ
|
+$6.41M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.72M |
| 5 |
FIGS
FIGS
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MongoDB
MDB
|
+$7M |
| 2 |
Charles River Laboratories
CRL
|
+$6.37M |
| 3 |
Floor & Decor
FND
|
+$5.83M |
| 4 |
Bruker
BRKR
|
+$5.34M |
| 5 |
Asana
ASAN
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Healthcare | 21.49% |
| 3 | Industrials | 12.78% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
D.R. Horton
DHI
$42.3B
| – | – |
-45,500
| Closed | -$3.82M |
|
902
Denali Therapeutics
DNLI
$3.82B
| – | – |
-15,200
| Closed | -$767K |
|
|
DOCU
903
DocuSign
DOCU
$10.7B
| – | – |
-5,500
| Closed | -$1.42M |
|
904
Dorman Products
DORM
$4.28B
| – | – |
-2,504
| Closed | -$237K |
|
905
Enanta Pharmaceuticals
ENTA
$367M
| – | – |
-12,954
| Closed | -$736K |
|
906
ESCO Technologies
ESE
$8.18B
| – | – |
-3,459
| Closed | -$266K |
|
|
ESGR
907
DELISTED
Enstar Group
ESGR
| – | – |
-1,200
| Closed | -$282K |
|
908
Establishment Labs
ESTA
$2.7B
| – | – |
-17,076
| Closed | -$1.22M |
|
909
EverQuote
EVER
$960M
| – | – |
-62,518
| Closed | -$1.17M |
|
910
Evogene
EVGN
$5.99M
| – | – |
-7,740
| Closed | -$204K |
|
911
Evercore
EVR
$13.2B
| – | – |
-4,528
| Closed | -$605K |
|
|
EXAS
912
DELISTED
Exact Sciences
EXAS
| – | – |
-9,900
| Closed | -$945K |
|
913
Fate Therapeutics
FATE
$270M
| – | – |
-19,482
| Closed | -$1.16M |
|
914
Fair Isaac
FICO
$31B
| – | – |
-1,300
| Closed | -$517K |
|
915
Comfort Systems
FIX
$57.2B
| – | – |
-5,500
| Closed | -$392K |
|
916
Flex
FLEX
$41.5B
| – | – |
-14,650
| Closed | -$195K |
|
|
917
Floor & Decor
FND
$6.14B
| – | – |
-48,287
| Closed | -$5.83M |
|
918
Fossil Group
FOSL
$262M
| – | – |
-24,694
| Closed | -$293K |
|
919
Frontline
FRO
$8.63B
| – | – |
-104,687
| Closed | -$956K |
|
920
Freshpet
FRPT
$3.01B
| – | – |
-4,884
| Closed | -$697K |
|
921
TechnipFMC
FTI
$28.9B
| – | – |
-208,505
| Closed | -$1.57M |
|
922
Fulcrum Therapeutics
FULC
$248M
| – | – |
-13,523
| Closed | -$381K |
|
923
Fiverr
FVRR
$417M
| – | – |
-2,769
| Closed | -$506K |
|
924
Gaia
GAIA
$47.6M
| – | – |
-15,457
| Closed | -$147K |
|
925
Gilead Sciences
GILD
$167B
| – | – |
-6,500
| Closed | -$454K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q4 2021 Portfolio in Review
As of Q4 2021, PDT Partners held 1,081 positions worth $1.31B, down 5.7% from $1.39B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.
PDT Partners withdrew a net $105M in Q4 2021, closing 229 positions and reducing 286 holdings. Its most notable exit was MongoDB, an estimated $7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, PDT Partners opened a new position in Allakos worth $940K.
- PDT Partners's largest Q4 2021 buy was Allakos: 96,046 shares worth $940K.
- PDT Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021, an estimated $5.72M increase.
- PDT Partners's biggest Q4 2021 reduction was Charles River Laboratories, cutting an estimated $6.37M.
- PDT Partners fully exited MongoDB in Q4 2021, selling an estimated $7M.
- PDT Partners's ten largest holdings make up 6.9% of its $1.31B portfolio in Q4 2021.
- PDT Partners opened 330 new positions and closed 229 in Q4 2021.
- PDT Partners's portfolio value fell 5.7% quarter-over-quarter to $1.31B.
Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.